Daniel Bollag Insider Profile
4 Followers
Daniel Bollag, Sr. VP Reg. Affairs & Quality at Ocular Therapeutix, holds 42.10K shares in Ocular Therapeutix (Ticker: OCUL), holds 141.46K shares in Ariad (Ticker: ~ARIA). Most recently, Daniel Bollag Bought ― shares of Ocular Therapeutix on Dec 10, 2018 for an estimated value of $100.22K.
Daniel Bollag's Trading History
| OCULOcular Therapeutix | Dec 10, 2018 | Sr. VP Reg. Affairs & Quality | Informative Buy | 100.22K | $261.44K | |
| ~ARIAAriad | Feb 16, 2017 | ― | Uninformative Sell | ― | $3.39M |
You May Also Like
Daniel Bollag insider profile FAQ
What is the percentage of profitable transactions made by Daniel Bollag?
The percentage of profitable transactions made by Daniel Bollag is 67%.
What is the average return per transaction made by Daniel Bollag?
The average return per transaction made by Daniel Bollag is 13.40%.
What stocks does Daniel Bollag hold?
Daniel Bollag holds: OCUL, ~ARIA stocks.
What was Daniel Bollag’s latest transaction?
Daniel Bollag’s latest transaction was an Informative Buy of $100.22K.
What was Daniel Bollag's most profitable transaction?
Daniel Bollag’s most profitable transaction was an Informative Buy of OCUL stock on December 8, 2017. The return on the trade was 40.20%.
What is Daniel Bollag's role in Ocular Therapeutix?
Daniel Bollag's role in Ocular Therapeutix is Sr. VP Reg. Affairs & Quality.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
